Your SlideShare is downloading. ×
Osce-ong
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Osce-ong

701

Published on

Published in: Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
701
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
21
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. A B C OSCE O&G , Family Medicine
  • 2.
    • 1.Identify exhibit A,B,C
    • A-COCP-21 biji,POP28 biji
    • B-depoprovera-injectable progestrone
    • C-IUCD-cooper bearing IUD
    • 2. What is the mode of action of exhibit A
    • Inhibit FSH and LH-inhibit ovulation
    • Making the endometrium atrophy-not well develop
    • Changes cervical mucus-prevent penetration of sperm(progestrone)
    • 3. State 2 indication for exhibit B
      • Non compliance with OCP
      • OCP contraindication-CVS,DVT,HPT,SLE,hepatic disease,thromboembolism
    • 3. State 2 contraindication for C-PID,previous ectooic pregnancy,std,malformatiojn of uterus,cooper allergic,multiple partner,active genitourinary infection

×